➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Express Scripts
Boehringer Ingelheim
Dow
AstraZeneca

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Kolcraft Enterprises, Inc. v. Artsana USA, Inc. (N.D. Ill. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Kolcraft Enterprises, Inc. v. Artsana USA, Inc. (N.D. Ill. 2013)

Docket   Start Trial Date Filed 2013-07-08
Court District Court, N.D. Illinois Date Terminated
Cause 35:271 Patent Infringement Assigned To Sara Lee Ellis
Jury Demand Both Referred To
Parties ARTSANA USA, INC.; ARTSANA, S.P.A.; KOLCRAFT ENTERPRISES, INC.
Patents 6,585,993; 6,955,884; 7,955,596; 9,585,955
Attorneys Anthony S. Volpe; Christopher William Niro; James Kenneth Borcia; Laura Anne Kenneally; Olivia Luk Bedi; Olivia T. Luk; Raymond Pardo Niro , Jr.; Ryan William O'Donnell
Firms Anthony S. Volpe
Link to Docket External link to docket
Biologic Drugs cited in Kolcraft Enterprises, Inc. v. Artsana USA, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Kolcraft Enterprises, Inc. v. Artsana USA, Inc. (N.D. Ill. 2013)

Date Filed Document No. Description Snippet Link To Document
2020-03-27 256 20 of the ‘993 patent. See Doc. 243 at 5–6. For example, while claim 20 of the ‘993 patent describes … the ‘501 patent, as well as U.S. Patent No. 7,376,993 (“the ‘993 patent”). The ‘501 patent issued on…“the ‘993 patent case”), bars Kolcraft’s claims here. Although the judgment in the ‘993 patent case does…U.S. Patent No. 8,257,229 (“the ‘229 patent”), which itself is a continuation of the ‘993 patent. In …infringe claims 20 and 28–31 of the ‘993 patent. Claim 20 of the ‘993 patent, as amended during an inter partes External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
AstraZeneca
McKesson
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.